Press Releases

OVERLAND PARK, KANSAS, UNITED STATES, December 2, 2020 /EINPresswire.com/ — Nemechek Technologies is proud to announce publication of a peer-reviewed research article by its CEO, Patrick Nemechek D.O. Entitled, ‘Transcutaneous Vagus Nerve Stimulation is Associated with Lower Mechanical Ventilation and Mortality in COVID-19 Patients: An interim Safety Analysis’, the study reveals that transcutaneous vagus nerve stimulation (tVNS) …

PR: Vagus Nerve Stimulation Associated with Fewer Deaths in Hospitalized COVID-19 Patients, Dec 2, 2020 Read More »

Is Bio-Electric Medicine the Next Frontier of Therapy for Coronavirus Victims? Just Published – Dr. Patrick Nemechek proposes new technology to suppress COVID-19 cytokine storm. Overland Park, Kansas, June 29, 2020 – Nemechek Technologies, LLC announced the publication of a peer-reviewed article by Patrick Nemechek D.O. in The Journal of Integrative Clinical Medicine.  Entitled, ‘Transcutaneous …

PR: Bioelectric Medicine and Coronavirus? ,June 29, 2020 Read More »

‘Vagus Nerve Stimulation is an Ideal Therapeutic Candidate for COVID-19 Infection’ Patrick Nemechek, D.O. – Published in The Journal of Emerging Diseases and Virology OVERLAND PARK, KANSAS, UNITED STATES, June 22, 2020 /EINPresswire.com/ — Nemechek Technologies, LLC announced the publication of a peer-reviewed article by Patrick Nemechek D.O. on the advantages of vagus nerve stimulation …

PR: VNS for COVID-19?, June 22, 2020 Read More »

Proposed South African Study Targets COVID-19 with Bio-Electric Therapy Vagus Nerve Stimulation (VNS) trial seeks to mitigate the deadly Cytokine Storm. Overland Park, Kansas, June 2, 2020 –Nemechek Technologies, Overland Park, Kansas and LT Clinical Research (Pty) LTD, Centurion, South Africa have agreed to collaborate to establish a clinical trial focused on the therapeutic effect …

PR: NemeTech Enters Collaborative Agreement, June 2, 2020 Read More »

Bio-Electric Therapy Targets Deadly COVID-19 Cytokine Storm Vagus Nerve Stimulation (VNS) Trial Seeks to Mitigate Dangerous Immune Response. Overland Park, Kansas, May 20, 2020 – Dr. Patrick Nemechek, founder of Nemechek Technologies, registered a study with ClinicalTrials.Gov to determine the therapeutic effect of transcutaneous auricular vagus nerve stimulation (tVNS) in patients with moderate, severe, or …

PR: Planning Clinical Trial of VNS vs. COVID-19, May 20, 2020 Read More »

Bio-Electric Therapy Targets Deadly COVID-19 Cytokine Storm Vagus Nerve Stimulation (VNS) Trial Seeks to Mitigate Dangerous Immune Response. Overland Park, Kansas, May 20, 2020 – Dr. Patrick Nemechek, founder of Nemechek Technologies, registered a study with ClinicalTrials.Gov to determine the therapeutic effect of transcutaneous vagus nerve stimulation (tVNS) in patients with moderate, severe, or critical …

PR: – May 4, 2020 Read More »